Filing Details

Accession Number:
0001246360-15-002696
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-16 16:00:09
Reporting Period:
2015-07-14
Filing Date:
2015-07-16
Accepted Time:
2015-07-16 16:00:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1485966 A Carol Surface 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Svp, Chief Hr Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-07-14 8,239 $57.65 80,947 No 4 M Direct
Ordinary Shares Disposition 2015-07-14 13,722 $75.83 67,225 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (right to buy) Disposition 2015-07-14 8,239 $0.00 8,239 $57.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,719 2014-10-28 2023-10-28 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 568 Indirect 401(k)
Footnotes
  1. This balance increased by 556 shares due to exempt transactions such as dividend reinvestment.
  2. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.8210 to $75.8450, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.